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Abstract
The innate immune system critically shapes diabetogenic adaptive immunity during type 1
diabetes (T1D) pathogenesis. While the role of tissue-infiltrating monocyte-derived macro-
phages in T1D is well established, the role of their tissue-resident counterparts remains
undefined. We now demonstrate that islet resident macrophages (IRMs) from non-autoim-
mune mice have an immunoregulatory phenotype and powerfully induce FoxP3+ Tregs in
vitro. The immunoregulatory phenotype and function of IRMs is compromised by TLR4 acti-
vation in vitro. Moreover, as T1D approaches in NOD mice, the immunoregulatory pheno-
type of IRMs is diminished as is their relative abundance compared to immunostimulatory
DCs. Our findings suggest that maintenance of IRM abundance and their immunoregulatory
phenotype may constitute a novel therapeutic strategy to prevent and/or cure T1D.
Introduction
Autoimmune type 1 diabetes (T1D) arises from T-cell mediated destruction of insulin-produc-
ing β-cells. However, alterations in innate immune cells profoundly influence diabetogenic T
cell immunity and T1D pathogenesis [1]. In non-obese diabetic (NOD) mice, T1D pathogene-
sis is associated with elevated inflammatory cytokine secretion by monocyte-derived macro-
phages [2] and the emergence of an inflammatory Batf3+ intra-islet dendritic cell (DC) subset
[3]. In humans, monocytes and myeloid DCs from individuals with T1D have altered TLR
responses that give rise to heightened NF-κB activation and pro-inflammatory cytokine secre-
tion [4].
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Circulating monocyte-derived, tissue-infiltrating macrophages play a pro-inflammatory role
in T1D; however, the role of their tissue-resident counterparts remains undefined. Tissue-resi-
dent macrophages (TRMs) are an Ly6C- lineage that arises from yolk-sac derived progenitors
[5, 6], distinguishing them from Ly6C+ monocyte-derived macrophages that are replenished by
bone marrow-derived circulating progenitors [7]. Recently, we identified a CD169+TIM-4+
TRM subset in heart and skin that migrates upon activation to draining lymph nodes, produces
TGFβ, induces FoxP3+ Tregs, and promotes allograft survival [8]. This TRM population joins
kindred immunoregulatory Ly6C- subsets of bronchoalveolar TRMs that suppress asthmatic
lung inflammation [9] and adipose TRMs that control local inflammation and insulin resistance
[10]. Thus, many TRM subsets are immunoregulatory in the steady state; however, the influ-
ence of inflammation on the immunoregulatory phenotype and function of TRMs has not been
intensively studied.
A CD169+ (MOMA-1+) population has been identified in pre-diabetic NODmice by
immunohistochemistry [11], suggesting that a population of TRMs might be present in the
pancreatic islets of T1D-prone mice. However, whether these cells: i) are TRMs, ii) possess
immunoregulatory phenotype and function in the steady state, or iii) exhibit phenotypic or
functional plasticity, remains untested. To this end, we have identified a CD169+ islet-dwelling
TRM subset and analyzed its immunoregulatory phenotype and function in quiescence,
inflammation and autoimmune T1D.
Materials & Methods
Mice
C57BL/6J (B6), female NOD/LtJ (NOD) and female NOR/LtJ (NOR) mice were obtained from
the Jackson Laboratories (Bar Harbor, ME). Founder bm12 (B6(C)-H2-Ab1bm12/HkEgJ), B6.
g7 (B6.NODD17Mit21-D17Mit10/LtJ), and ABM TCR [12] transgenic mice bearing the FoxP3/GFP
reporter mice were maintained in our colony. Founder BDC2.5 TCR transgenic mice on the
B6.g7 background [13] were obtained from Drs. Mathis and Benoist (Harvard Medical School,
Boston, MA) and maintained as heterozygotes in our colony by paired mating with wild type
B6.g7 mice. Glucose tolerance was defined as AUC100mg/dl<6,000 and blood glucose<150mg/
dl at 120 minutes after i.p. injection of glucose (3g/kg). All mice were certified to be specific
pathogen-free conditions. All animal experiments were performed under a protocol reviewed
and approved by the Institutional Animal Care and Use Committee at Beth Israel Deaconess
Medical Center (Boston, MA) and in accordance with the U.S. Department of Health and
Human Services’ Guide for the Care and Use of Laboratory Animals.
Immunofluorescence microscopy
Pancreases were snap-frozen; stained with rat anti-mouse CD169, goat anti-mouse TIM-4
(R&D Systems, Minneapolis, MN) and a triple antibody cocktail containing rabbit anti-human
glucagon, somatostatin, and pancreatic polypeptide. Images were acquired on an LSM 510
Meta using a plan-apochromat 1.3 numerical aperture 40x objective with oil (Carl Zeiss,
Thornwood, NY).
Isolation of islet resident leukocytes
Pancreatic islets were purified as described [14], gravity washed, and incubated at 37°C in
HBSS containing 0.25% trypsin, 2mM EDTA, and 0.1mg/ml DNAse with agitation (120 RPM)
for 10 minutes. Digestion was stopped by adding FBS to a 20% final concentration and placing
samples on ice. Single cell suspensions were then stained with the indicated viability dye and
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antibodies. Absolute numbers were determined using CountBright absolute counting beads
(Life Technologies, Carlsbad, CA).
FACS analysis and cell sorting
The following monoclonal antibodies were used: anti-CD11b (M1/70), anti-CD11c (N418),
anti-CD16/32 (93), anti-CD39 (DMS1), anti-CD45 (30-F11), anti-CD73 (TY/11.8), anti-
CD169 (3D6.112), anti-CX3CR1 (SA011F11), anti-F4/80 (BM8), anti-Ly6C (HK1.4), anti-
TIM-4 (5G3), anti-CD4 (GK1.5), anti-CD25 (PC61), anti-CD44 (IM7), anti-CD62L (MEL-
14), anti-Vα2 (B20.1), anti-Vβ4 (KT4), anti-Vβ8.1/2 (KJ16-133.18), and anti-FoxP3 (FJK-16s).
Live/Dead Yellow Fixable Stain, Fixable Viability Dye eFluor 780 or DAPI were utilized to
assess viability. Intracellular FoxP3 staining was performed using the Fixation/Permeabiliza-
tion Staining Buffer Set (eBioscience, San Diego, CA). Data acquisition and/or cell sorting was
performed on a special-order 5-laser BD LSRII flow cytometer, Beckman Coulter Gallios, or
BD FACS Aria or Aria II instrument. Purity after sorting was routinely>95%. Analysis was
performed using FlowJo software. Mean fluorescence intensities (MFIs) were calculated using
the geometric mean of the appropriate fluorescence channel in FlowJo. Expansion Indices were
determined using the embedded FlowJo algorithm.
Mixed lymphocyte reactions
Live CD45+Ly6C-CD11c+F4/80+CD16/32+ IRMs, CD45+Ly6C-CD11c+F4/80-CD16/32-
IRDCs, or splenic CD11chiCD11blow DCs (typically 2.5 x 103) were FACS sorted and incubated
at a 1:20 ratio with FACS-sorted ABM CD4+FoxP3/GFP- T cells or B6.g7/BDC2.5 CD4+-
CD44-CD25-CD62Lhi T cells (typically 0.5 x 105) labeled with CellTrace Violet (Life Technolo-
gies). Culture media was IMDM supplemented with 2-mercaptoethanol, 10% heat-inactivated
FBS, 20ng/ml IL-2, and penicillin/streptomycin/L-glutamine. The agonistic 1068–56 peptide
(KVAPVWVRMME, Genscript, Piscataway, NJ) was added to BDC2.5 cultures at a final con-
centration of 2.5μM [15]. After 96 h, ABM CD4+Vα2+Vβ8+ or BDC2.5 CD4+Vβ4+ transgenic
T cells were stained with the indicated antibodies. LPS from E. coli was re-purified as previously
described [16] and added to cultures at a final concentration of 1μg/ml.
Quantitation of IL-6 in supernatants
IL-6 was measured in the supernatants of MLR cultures using a cytokine bead array. The con-
centration of the experimental samples was interpolated using a 4-parameter logistic non-lin-
ear regression model.
Real-time PCR
Cells were FACS-sorted or resuspended into cell lysis buffer. cDNA was synthesized from col-
umn-purified RNA and pre-amplified for 10 cycles using the PreAmp (Life Technologies) tar-
get-specific pre-amplification system. Real-time PCR was performed using TaqMan probe/
primer sets from Life Technologies (Table 1). Data were normalized to GAPDH using the ΔCT
method.
Statistics
Statistical analyses were performed with Prism software (GraphPad, La Jolla, CA). Means of
two groups were compared by an unpaired t test. Means of three or more groups were com-
pared using a one-way ANOVA with Bonferroni’s post-test. All error bars are +/- S.D. Values
of p< 0.05 were deemed statistically significant.
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Results
CD169+TIM-4+ cells are located at the islet perimeter in C57BL/6 and
NODmice
To assess whether a CD169+TIM-4+ TRM population exists in pancreatic islets, we performed
immunofluorescence staining on pancreas from C57BL/6 (B6) mice and NODmice. B6 mice
are completely free of insulitis and T1D. NODmice spontaneously develop invasive insulitis
by 5 weeks-of-age and, beginning at 12 weeks of age, develop T1D. We determined the relative
position of CD169+TIM-4+ cells with respect to pancreatic islets by co-staining frozen pan-
creas sections with anti-CD169, anti-TIM-4, and a triple antibody cocktail that stains endo-
crine cells expressing glucagon (α), somatostatin (δ), and pancreatic polypeptide (γ). We
routinely observe CD169+TIM-4+ (Fig 1 and S1 Fig) cells at the islet perimeter in B6 mice.
CD169+TIM-4+ cells are increased in abundance but remain at the islet perimeter in pre-dia-
betic and diabetic NODmice (S1 Fig).
Islet resident macrophages are Ly6C-CD11c+CD16/32+F4/80+
TRM subsets are often identified by a complex extended phenotype that consists of a lack of
Ly6C expression [10] as well as the presence of multiple macrophage markers, including
CD11c and, F4/80, [9, 17]. While more broadly expressed in mice, CD16 (FcγRIII) and CD32
(FcγRII) are expressed highly on TRM populations in humans [17, 18] and may be useful to
identify murine TRMs in conjunction with other markers [19]. To identify and isolate putative
TRMs from pancreatic islets, purified B6 and NOD islets were enzymatically digested and ana-
lyzed for subsets expressing CD45, Ly6C, CD11c, CD16/32, and F4/80 by flow cytometry.
Within the viable CD45+Ly6C-CD11c+ fraction (Fig 2A, left panel), we observe two distinct
populations. We designate the dominant Ly6C-CD11c+CD16/32+F4/80+ subset (Fig 2A, right
panel) as islet resident macrophages (IRMs). A smaller Ly6C-CD11c+CD16/32-F4/80- subset
(Fig 2A, right panel) is designated as islet resident dendritic cells (IRDCs), insofar as these cells
are F4/80- and exhibit DC-like functional properties that will be described later. Validating our
designation of the extended Ly6C-CD11c+CD16/32+F4/80+ phenotype as a TRM subset,
FACS-sorted B6 IRMs express more Csf1r transcripts (Fig 2B) and higher levels of the TRM
markers CD169, TIM-4 and CX3CR1 (Fig 2C) as compared to IRDCs. NOD IRMs exhibit a
similar TRM-like phenotype (S2 Fig).
Islet resident macrophages powerfully induce FoxP3+ Tregs in vitro but
their immunoregulatory function is compromised by TLR4 stimulation
To test whether IRMs from insulitis and T1D-free mice are functionally immunoregulatory,
we performed mixed lymphocyte reactions (MLRs) with IRM, IRDC or splenic DC stimulator
cells from bm12 mice (I-Abm12) and FoxP3/GFP-CD4+ T cells from ABM TCR transgenic
Table 1. Table of probe/primer sets used for real-time PCR.
Gene Protein TaqMan Assay ID
Csf1r CSF1R Mm01266652
Entpd1 CD39 Mm00515447
Ccl2 CCL2/MCP-1 Mm00441242
Il1b IL-1β Mm00434228
Il6 IL-6 Mm00446190
Gapdh GAPDH 4352339E
doi:10.1371/journal.pone.0150792.t001
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mice. ABMmice express a clonotypic anti-I-Abm12 transgenic TCR and a FoxP3/GFP reporter
[12]. After 4 days in the MLR, CD4+ ABM T cells stimulated by bm12 IRM, IRDC or splenic
DC stimulator cells were collected and analyzed for proliferation by CellTrace Violet dilution
and Treg conversion by de novo FoxP3/GFP reporter expression. At the 1:20 stimulator:T cell
Fig 1. TIM-4+CD169+ cells are present at the islet perimeter in C57BL/6 mice. Frozen pancreas sections
from C57BL/6 mice (n = 5) were stained with a triple antibody cocktail reactive to glucagon, somatostatin, and
pancreatic polypeptide (Light Blue); anti-TIM-4 (Green); anti-CD169 (Red); and Hoechst (Blue). White arrows
indicate CD169+TIM-4+ cells. Individual panels are shown in S1 Fig. Photomicrographs were taken using
40x objective magnification. The bottom panel shows an enlarged area of the photomicrograph in the top
panel.
doi:10.1371/journal.pone.0150792.g001
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ratio used in our experiments, we observed inter-experimental variability in the frequency of
non-activated T cells that failed to upregulate CD25. As proliferation and Treg conversion can-
not be determined for this non-activated CD25- population, which likely failed to encounter
antigen, we performed proliferation and Treg conversion analyses using an activated (CD25+)
CD4+ TCR transgenic T cell gate. Whereas IRMs induce less proliferation as compared to
IRDCs or splenic DCs (Fig 3A), IRMs induce a much higher frequency of FoxP3/GFP expres-
sion (Fig 3B and 3C; p<0.001). Strikingly, stimulation of the MLR by LPS, a TLR4 agonist,
reduces the frequency of FoxP3/GFP+ T cells (20.9% for untreated IRMs vs. 9.3% for LPS-stim-
ulated IRMs, p<0.01; Fig 3C). This decrease in FoxP3+ Treg frequency correlates with an
increase in the Treg inhibitory cytokine IL-6 in the supernatant (Fig 3D; p<0.001).
TLR4 activation compromises the immunoregulatory phenotype of islet
resident macrophages
We next determined whether TLR4 activation compromised the immunoregulatory phenotype
of IRMs from non-autoimmune B6 mice. At baseline, B6 IRMs relative to IRDCs express more
CD39 and CD73, which collectively cleave pro-inflammatory ATP into anti-inflammatory aden-
osine [20], and galectin-9, which induces apoptosis in TIM-3+ effector T cells [21] (Fig 4A).
IRMs stimulated with LPS dramatically downregulate immunoregulatory Entpd1 (CD39) tran-
script expression and upregulate pro-inflammatory Ccl2, Il6, and Il1b transcript expression rela-
tive to untreated control IRMs (Fig 4B). In contrast to TLR4 stimulation, anti-CD40 stimulated
IRMs maintain Entpd1 transcript expression and only modestly upregulate Il6 and Il1b tran-
script expression (Fig 4B). An in increase in IL-6 production by LPS stimulated (13.94±4.38pg/
ml) as compared to both unstimulated (2.20±0.34 pg/ml, p<0.001 in Bonferroni’s post test) and
anti-CD40 stimulated (2.74±0.31pg/ml, p<0.001 in Bonferroni’s post test) IRMs was confirmed
by cytometric bead array (ANOVA p<0.001). As IRMs became adherent to the plate during cul-
ture, a decrease in CD39 expression could not be validated at the protein level.
Fig 2. Intra-islet CD45+CD11c+Ly6C-F4/80+CD16/32+ cells from C57BL/6 mice exhibit a tissue-
resident macrophage phenotype. Purified C57BL/6 pancreatic islets were enzymatically digested and
stained with anti-CD45, anti-CD11c, anti-Ly6C, anti-F4/80, and anti-CD16/32. (A) Identification of live CD45+
(not shown) CD11c+Ly6C- (left panel) cells that exhibit an islet-resident macrophage (IRM, F4/80+CD16/32
+) or DC (IRDC, F4/80-CD16/32-) phenotype (right panel) are shown. (B) FACS-sorted IRMs and IRDCs
were analyzed for Csf1r transcript levels by real-time PCR. Data from independent experiments (n = 4 per
group) and their mean are plotted; groups were compared with an unpaired t test. (C) Histograms show
protein expression of CD169, TIM-4, and CX3CR1 on gated IRM (solid line) and IRDC (dashed line) subsets.
Shaded histograms are the fluorescence minus one (FMO) controls. Geometric mean fluorescence
intensities (MFIs) are indicated parenthetically. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0150792.g002
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Fig 3. Islet resident macrophages induce Tregs through a mechanism that is dampened by TLR4
stimulation. FACS-sorted ABMCD4+FoxP3/GFP- TCR transgenic T cells were CellTrace violet labeled and
cultured with FACS-sorted live IRMs (CD45+Ly6C-CD11c+F4/80+CD16/32+), IRDCs (CD45+Ly6C-CD11c
+F4/80-CD16/32-), or splenic DCs (CD11chiCD11blow) from bm12 (I-Abm12) mice for 96 h. (A) Proliferation of
gated live CD25+CD4+Vα2+Vβ8+ ABM TCR transgenic T cells stimulated with IRM (solid line), IRDC (long
dashed line), or splenic DC (short dashed line) stimulators is depicted in a histogram. The shaded histogram
represents the unstimulated control. Representative data from 3 independent experiments are shown. (B)
FoxP3/GFP expression in gated live activated CD25+CD4+Vα2+Vβ8+ ABM TCR transgenic T cells is shown
from a representative experiment. (C) FoxP3/GFP expression in gated live activated CD25+CD4+Vα2+Vβ8
+ ABM TCR transgenic T cells from independent experiments (n = 4–6 per group) are shown in scatter plots.
Groups were compared by ANOVA (p<0.01) and Bonferroni’s post-test (***, p<0.001). (D) Concentration of
IL-6 (pg/ml) in the supernatant of independent MLR cultures (n = 4–6 per group) is shown in a scatter plot.
Groups were compared by ANOVA (p<0.01) and Bonferroni’s post-test (***, p<0.001).
doi:10.1371/journal.pone.0150792.g003
Fig 4. Islet resident macrophages possess an immunoregulatory phenotype that is compromised by
TLR4 activation. (A) IRMs (solid line) and IRDCs (dashed line) were analyzed directly ex vivo by flow
cytometry for CD39, CD73 and galectin-9 using the CD45+Ly6C-CD11c+F4/80+CD16/32+ gate. Shaded
histograms are the FMO controls and MFIs are indicated parenthetically. Representative data are shown
from one of three independent experiments. (B) FACS-sorted B6 IRMs were stimulated with 1 μg/ml of LPS or
10 μg/ml of agonistic anti-CD40. After 72 h, mRNA from cultured cells was analyzed by real-time PCR for
Entpd1 (CD39), Ccl2, Il1b, and Il6 transcripts. Each point represents data from an independent experiment
(n = 3–4 per group).
doi:10.1371/journal.pone.0150792.g004
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IRMs from euglycemic NOD, NOR and B6.g7 mice robustly induce
FoxP3+ Tregs in diabetogenic BDC2.5 T cells
We next tested whether T1D-prone NOD IRMs are inherently defective in their ability to
induce FoxP3+ T cells as compared to IRMs from non-T1D strains. To test this, we performed
MLRs utilizing FACS-sorted naïve CD4+CD25-CD44-CD62Lhi BDC2.5 TCR transgenic
responder T cells [13, 22], which express a diabetogenic (I-Ag7) clonotypic TCR [15], and pep-
tide-pulsed FACS-sorted IRMs or splenic DCs from B6.g7 (H-2g7), NOR (H-2g7), NOD (H-
2g7) or B6 (H-2b) mice. B6.g7 mice contain the NODMHC region (H-2g7) but, like B6 mice,
are insulitis and T1D-free [23]. Congenic NOR mice contain B6 introgressions on chromo-
somes 2, 4, 11, and 12, exhibit non-invasive peri-islet insulitis, and do not develop T1D [24].
As noted above, FoxP3 conversion was assessed using an activated (CD25+) CD4+ TCR trans-
genic T cell gate in order to eliminate the confounding influence of the non-activated CD25- T
cells fraction.
Unpulsed IRMs from mice bearing the H-2g7 MHC region induce activation, proliferation
(Fig 5A), and robust FoxP3 expression (Fig 5B) in naïve BDC2.5 T cells. Proliferation is
increased in peptide-pulsed IRMs as compared to unpulsed IRMs. Moreover, while peptide-
pulsed IRMs induce a lower frequency of FoxP3+ Tregs relative to unpulsed IRMs, both
unpulsed and peptide-pulsed IRMs induce much more abundant FoxP3 expression compared
to peptide-pulsed splenic DCs. Interestingly, robust FoxP3 expression is induced in peptide-
pulsed and unpulsed by IRMs from euglycemic NOD IRMs as well as NOR and B6.g7 control
IRMs (Fig 5C).
IRMs from T1D NODmice undergo phenotypic plasticity and express
less immunoregulatory CD39 as compared to IRMs from NORmice
We next tested the hypothesis that IRMs, a cell population whose phenotype is altered by
TLR4 stimulation, might manifest changes in phenotype associated with age that herald T1D
onset. Interestingly, expression of CD39 is reduced on IRMs in diabetic (p<0.01) and non-dia-
betic NOD (p<0.05) mice as compared to control NOR mice at 15 weeks of age (Fig 6). In con-
trast, expression of CD39 is similar between NOD and NOR mice at earlier time-points (Fig 6,
p = N.S.).
The balance of islet resident APCs tilts from islet resident macrophages
to islet resident DCs in T1D NOD relative to control mice
We next tested the hypothesis that the balance of intra-islet IRMs to DCs is altered during T1D
pathogenesis. To test this, we enumerated intra-islet APC populations in 5-, 9-, and 15-week-
old NODmice and age-matched NOR control mice. NODmice exhibit mild peri-islet insulitis
at 5 weeks, moderate peri-islet insulitis at 9 weeks, and invasive insulitis at 15 weeks. Fifteen-
week-old NODmice were stratified into non-diabetic, diabetic, and glucose intolerant cohorts
based on the results of an i.p. glucose tolerance test (IPGTT) one day before analysis.
The ratio of immunoinflammatory IRDCs to IRMs is virtually identical in young 5-week-old
NOD and NORmice (Fig 7A, p = N.S.). However, the ratio of IRDCs to IRMs is dramatically
increased in 9-week-old (p<0.01) and 15-week-old (p<0.001) NODmice relative to age-matched
NORmice. In order to determine whether the increased frequency of IRDCs (CD45+Ly6C-
CD11c+CD16/32-F4/80-) relative to IRMs (CD45+Ly6C-CD11c+CD16/32+F4/80+) is due to a
decrease in IRMs and/or an increase in IRDCs, we quantified the absolute number of IRMs and
IRDCs per islet in each group. At 9 and 15 weeks of age, IRMs, IRDCs, and tissue-infiltrating
(CD11b+Ly6Chi) macrophages are all increased in absolute abundance in NOD as compared to
Immunoregulatory Islet Resident Macrophages in T1D
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Fig 5. IRMs from B6.g7, NOD, and NOR induce FoxP3+ Tregs in the diabetogenic BDC2.5 TCR
transgenic clone. CellTrace Violet labeled CD4+CD25-CD44-CD62Lhi naïve T cells from B6.g7/BDC2.5
TCR transgenic mice were cultured for 96 h with IRMs or CD11chiCD11blow splenic DCs from the indicated
strain pulsed with 2.5μM of the indicated agonist peptide. (A) CD25 upregulation and proliferation are shown
for gated live CD4+Vβ4+ transgenic BDC2.5 T cells stimulated with B6.g7 (H-2g7) splenic DCs, B6.g7 (H-2g7)
IRMs, or B6 (H-2b) IRMs pulsed with the agonistic 1068–56 peptide (left column) or no peptide (right column).
Immunoregulatory Islet Resident Macrophages in T1D
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NORmice (Fig 7B). In contrast, all three populations are indistinguishable in absolute number
between young 5-week-old NOD and NORmice (Fig 7B).
Discussion
Immunoregulatory TRM subsets are present in skin, heart [8], lung [9], and adipose tissue
[10]. We now report the characterization of an IRM population with immunoregulatory phe-
notype and function. As T1D approaches, the immunoregulatory phenotype of IRMs is dimin-
ished as is their relative abundance as compared to immunoinflammatory DCs. Both of these
changes are likely relevant to the onset of overt T1D.
Relative to IRDCs, IRMs more abundantly express immunoregulatory CD39, CD73, and
galectin-9. The role of other T cell checkpoints, including PD1/PDL1 [25] and ICOSL [26], in
IRM biology is not certain and warrants further study as these pathways play an important role
in regulating autoimmune T1D pathogenesis. Compared to DCs, IRMs also more powerfully
induce FoxP3+ Tregs in the MLR. However, TLR4 activation reduces FoxP3+ Treg induction
by IRMs, possibly related to the downregulation of immunoregulatory CD39 transcripts and
the upregulation of pro-inflammatory CCL2, IL-6, and IL-1β transcripts. Corroborating our in
vitro findings, there is an age-related loss of CD39 expression by IRMs in 15-week-old NOD
mice relative to diabetes-resistant controls. However, IRMs from NOD, NOR, and B6.g7 mice
are similar in their ability to induce FoxP3+ Tregs in vitro, suggesting that IRMs from NOD
mice are not inherently defective in their ability to induce Tregs.
It is still possible that IRM plasticity compromises other immunoregulatory functions such
as attenuating local inflammation [9, 10]. Loss of CD39 function, and the catabolism of pro-
inflammatory ATP into anti-inflammatory adenosine as a consequence, is associated with other
T cell dependent autoimmune diseases [27]. TRMs from type 2 diabetic mice undergo pro-
inflammatory phenotypic plasticity [28]. Thus, IRM plasticity provides new potential mecha-
nisms by which TLR activation may incite T1D [29, 30] and warrants closer examination.
The expansion index for the gated live activated CD4+Vβ4+CD25+ population was determined using FlowJo
analysis software and is noted in the upper-left corner. (B) FoxP3 expression is shown for the gated live
activated CD4+Vβ4+CD25+ population. (C) Percent of gated live CD4+Vβ4+CD25+ transgenic T cells that
acquire FoxP3 expression after culture with IRMs from the indicated strain are shown from independent
experiments (n = 3–4 per strain). A OneWay ANOVA indicated no significant difference among groups with
(p = 0.95) or without peptide (p = 0.64).
doi:10.1371/journal.pone.0150792.g005
Fig 6. Decreased CD39 protein expression by islet resident macrophages heralds T1D in NODmice.
The MFI of CD39 expression on IRMs from NOD and NORmice (n = 5 per group pooled from 2 independent
experiments) was analyzed by flow cytometry using the CD45+Ly6C-CD11c+F4/80+CD16/32+ gate. Since
each time-point was acquired separately, inter-graph comparison of MFIs is not possible. NOD groups were
compared to the NOR control group using an unpaired t test (*, p<0.05, **, p<0.01).
doi:10.1371/journal.pone.0150792.g006
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The absolute number of IRMs increases but its proportion relative to inflammatory IRDCs
is diminished in non-diabetic and diabetic NOD mice. This suggests that a shift in the balance
of intra-islet APCs from one that favors IRMs to one that favors inflammatory IRDCs heralds
T1D. As the NOD and NOR differ at defined loci on chromosomes 2, 4 11, and 12, it seems
probable that one or more of these genetic intervals drives changes in the balance of intra-islet
APCs and, as a result, disease outcome.
The relationships and interactions between IRMs and other immunoregulatory lymphocyte
populations, such as regulatory B cells (Bregs), remains unclear. Like Tregs, Bregs play an
important role in protection from T1D [31–33]. While TRMs are known to recruit anti-inflam-
matory resident B1 cells to the peritoneum [34] and to induce germinal center B cell responses
Fig 7. A decrease in the proportion of immunoregulatory islet resident macrophages relative to
immunostimulatory islet resident DCs heralds T1D in NODmice. (A) The ratio of immunoinflammatory
IRDCs to immunoregulatory IRMs was calculated at the indicated time-points. Data from individual mice
(n = 7–10 per group) were pooled from 3–4 independent experiments. Data were compared with an unpaired
t test (**, p<0.01; ***, p<0.001). (B) The absolute number of IRMs (CD45+Ly6C-CD11c+F4/80+CD16/32+),
IRDCs (CD45+Ly6C-CD11c+F4/80-CD16/32-), and islet-infiltrating macrophages (CD45+Ly6C+CD11b+)
were calculated per islet for NOD and NOR control mice at the indicated ages. Means +/- S.D. are shown for
the same cohorts displayed in panel A. NOD groups were compared to the NOR control group utilizing an
unpaired t test (*, p<0.05; **, p<0.01; ***, p<0.001).
doi:10.1371/journal.pone.0150792.g007
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in the spleen [35], the impact of TRMs on immunoregulatory B cell development remains
uncertain and warrants further study.
We now demonstrate the existence of a functionally immunoregulatory population of islet
resident macrophages in non-autoimmune and T1D NODmice. As T1D approaches, the
immunoregulatory phenotype of IRMs is diminished as is their relative abundance as com-
pared to immunoinflammatory DCs. These results suggest that the maintenance of IRM abun-
dance and their immunoregulatory phenotype constitutes a potential therapeutic strategy to
prevent and/or cure T1D.
Supporting Information
S1 Fig. TIM-4+ and CD169+ cells are located at the islet perimeter in pre-diabetic NOD
mice. Frozen pancreas sections from B6, non-diabetic NOD and diabetic NODmice (n = 4–5
per strain) were stained with a triple antibody cocktail reactive to glucagon, somatostatin, and
pancreatic polypeptide (Light Blue); anti-TIM-4 (Green); anti-CD169 (Red); and DAPI (Blue).
White arrows indicate CD169+TIM-4+ cells. Photomicrographs were taken at 40x objective
magnification.
(TIF)
S2 Fig. Intra-islet CD45+CD11c+Ly6C-F4/80+CD16/32+ cells exhibit a tissue-resident
macrophage phenotype in NODmice.Histograms showing the expression of the tissue-resi-
dent macrophage markers CD169, TIM-4, and CX3CR1 on IRMs (solid line) isolated from
non-diabetic NODmice. Shaded histograms are the FMO controls. Data are representative of
two independent experiments.
(TIF)
Acknowledgments
We thank John Tigges, Vasilis Toxavidis and Virginia Camacho at the Flow Cytometry Core
facility at Beth Israel Deaconess Medical Center for their assistance with flow cytometry and
cell sorting.
Author Contributions
Conceived and designed the experiments: TBT KA PK TBS MK. Performed the experiments:
TBT KA PK LM VC JEA SK EC. Analyzed the data: TBT KA PK LM VC JEA SK EC. Wrote
the paper: TBT TBS MK.
References
1. Zipris D. Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008; 15
(4):326–31. doi: 10.1097/MED.0b013e3283073a46 PMID: 18594272.
2. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting
cells in NOD/Lt mice. Journal of immunology. 1993; 150(6):2534–43. PMID: 8450229.
3. Ferris ST, Carrero JA, Mohan JF, Calderon B, Murphy KM, Unanue ER. A minor subset of Batf3-depen-
dent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune
diabetes. Immunity. 2014; 41(4):657–69. doi: 10.1016/j.immuni.2014.09.012 PMID: 25367577;
PubMed Central PMCID: PMC4220295.
4. Meyers AJ, Shah RR, Gottlieb PA, Zipris D. Altered Toll-like receptor signaling pathways in human type
1 diabetes. J Mol Med (Berl). 2010; 88(12):1221–31. doi: 10.1007/s00109-010-0666-6 PMID:
20725710.
5. Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. Tissue-resident mac-
rophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015; 518(7540):547–
51. doi: 10.1038/nature13989 PMID: 25470051.
Immunoregulatory Islet Resident Macrophages in T1D
PLOSONE | DOI:10.1371/journal.pone.0150792 March 4, 2016 12 / 14
6. Hashimoto D, Chow A, Noizat C, Teo P, Beasley M, Leboeuf M, et al. Tissue-Resident Macrophages
Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes.
Immunity. 2013; 38(4):792–804. doi: 10.1016/j.immuni.2013.04.004 PMID: 23601688
7. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD, et al. Alternatively activated macro-
phages derived frommonocytes and tissue macrophages are phenotypically and functionally distinct.
Blood. 2014; 123(20):e110–22. doi: 10.1182/blood-2013-08-520619 PMID: 24695852; PubMed Cen-
tral PMCID: PMC4023427.
8. Thornley TB, Fang Z, Balasubramanian S, Larocca RA, GongW, Gupta S, et al. Fragile TIM-4-express-
ing tissue resident macrophages are migratory and immunoregulatory. The Journal of clinical investiga-
tion. 2014. doi: 10.1172/JCI73527 PMID: 24983317.
9. Soroosh P, Doherty TA, DuanW, Mehta AK, Choi H, Adams YF, et al. Lung-resident tissue macro-
phages generate Foxp3+ regulatory T cells and promote airway tolerance. Journal of Experimental
Medicine. 2013; 210. doi: 10.1084/jem.20121849
10. Takashi S, Hiroyasu K, Hisamichi N, Masahiro Y, Naoki T, Katsuhiro N, et al. Critical role of Trib1 in dif-
ferentiation of tissue-resident M2-like macrophages. Nature. 2013; 495. doi: 10.1038/nature11930
11. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen P, DardenneM, Drexhage H. Immunohistochemical
characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis
and beta-cell destruction in NODmice. Diabetes. 1994; 43(1a56de63-010b-588f-c03d-
4f40bb66eadc):667–742.
12. Backstrom BT, Muller U, Hausmann B, Palmer E. Positive selection through a motif in the alphabeta T
cell receptor. Science. 1998; 281(5378):835–8. PMID: 9694657.
13. Gonzalez A, Katz JD, Mattei MG, Kikutani H, Benoist C, Mathis D. Genetic control of diabetes progres-
sion. Immunity. 1997; 7(6):873–83. PMID: 9430232.
14. KoulmandaM, Budo E, Bonner-Weir S, Qipo A, Putheti P, Degauque N, et al. Modification of adverse
inflammation is required to cure new-onset type 1 diabetic hosts. Proc Natl Acad Sci U S A. 2007; 104
(32):13074–9. Epub 2007/08/03. 0705863104 [pii] doi: 10.1073/pnas.0705863104 PMID: 17670937;
PubMed Central PMCID: PMC1941818.
15. Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, Wilson DB. Identification of MHC class II-
restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabeto-
genic T cells from transgenic BDC2.5 nonobese diabetic mice. Journal of immunology. 2001; 166
(2):908–17. PMID: 11145667.
16. Thornley TB, BrehmMA, Markees TG, Shultz LD, Mordes JP, Welsh RM, et al. TLR agonists abrogate
costimulation blockade-induced prolongation of skin allografts. Journal of immunology. 2006; 176
(3):1561–70. PMID: 16424185.
17. Gordon S, Pluddemann A, Martinez Estrada F. Macrophage heterogeneity in tissues: phenotypic diver-
sity and functions. Immunol Rev. 2014; 262(1):36–55. doi: 10.1111/imr.12223 PMID: 25319326;
PubMed Central PMCID: PMCPMC4231239.
18. Viksman MY, Bochner BS, Peebles RS, Schleimer RP, Liu MC. Expression of activation markers on
alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge. Clin
Immunol. 2002; 104(1):77–85. PMID: 12139951.
19. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct
migratory properties. Immunity. 2003; 19(1):71–82. PMID: 12871640.
20. Deaglio S, Dwyer KM, GaoW, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by
CD39 and CD73 expressed on regulatory T cells mediates immune suppression. The Journal of experi-
mental medicine. 2007; 204(6):1257–65. Epub 2007/05/16. doi: 10.1084/jem.20062512 PMID:
17502665; PubMed Central PMCID: PMC2118603.
21. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 neg-
atively regulates T helper type 1 immunity. Nature immunology. 2005; 6(12):1245–52. PMID:
16286920.
22. Katz JD,Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through
pathogenesis. Cell. 1993; 74(6):1089–100. PMID: 8402882.
23. Yui MA, Muralidharan K, Moreno-Altamirano B, Perrin G, Chestnut K, Wakeland EK. Production of con-
genic mouse strains carrying NOD-derived diabetogenic genetic intervals: an approach for the genetic
dissection of complex traits. Mammalian genome: official journal of the International Mammalian
Genome Society. 1996; 7(5):331–4. PMID: 8661724.
24. Prochazka M, Serreze DV, Frankel WN, Leiter EH. NOR/Lt mice: MHC-matched diabetes-resistant
control strain for NODmice. Diabetes. 1992; 41(1):98–106. PMID: 1727742.
Immunoregulatory Islet Resident Macrophages in T1D
PLOSONE | DOI:10.1371/journal.pone.0150792 March 4, 2016 13 / 14
25. Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, et al. Mechanisms of PDL1-mediated
regulation of autoimmune diabetes. Clin Immunol. 2007; 125(1):16–25. doi: 10.1016/j.clim.2007.05.013
PMID: 17627890.
26. Riella LV, Dada S, Chabtini L, Smith B, Huang L, Dakle P, et al. B7h (ICOS-L) maintains tolerance at
the fetomaternal interface. Am J Pathol. 2013; 182(6):2204–13. doi: 10.1016/j.ajpath.2013.02.014
PMID: 23578385; PubMed Central PMCID: PMCPMC3668017.
27. Sauer AV, Brigida I, Carriglio N, Hernandez RJ, Scaramuzza S, Clavenna D, et al. Alterations in the
adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and
autoimmunity in ADA-deficient SCID. Blood. 2012; 119(6):1428–39. doi: 10.1182/blood-2011-07-
366781 PMID: 22184407; PubMed Central PMCID: PMC3426348.
28. Calderon B, Carrero JA, Ferris ST, Sojka DK, Moore L, Epelman S, et al. The pancreas anatomy condi-
tions the origin and properties of resident macrophages. The Journal of experimental medicine. 2015.
doi: 10.1084/jem.20150496 PMID: 26347472.
29. Zhang S, Zhong J, Yang P, Gong F, Wang CY. HMGB1, an innate alarmin, in the pathogenesis of type
1 diabetes. Int J Clin Exp Pathol. 2009; 3(1):24–38. PMID: 19918326; PubMed Central PMCID:
PMC2776260.
30. Triantafilou K, Triantafilou M. Coxsackievirus B4-induced cytokine production in pancreatic cells is
mediated through toll-like receptor 4. Journal of virology. 2004; 78(20):11313–20. doi: 10.1128/JVI.78.
20.11313-11320.2004 PMID: 15452251; PubMed Central PMCID: PMC521802.
31. Kleffel S, Vergani A, Tezza S, Ben Nasr M, Niewczas MA, Wong S, et al. Interleukin-10+ regulatory B
cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabe-
tes. 2015; 64(1):158–71. doi: 10.2337/db13-1639 PMID: 25187361; PubMed Central PMCID:
PMCPMC4274804.
32. Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Megret J, Ezine S, et al. Innate pro-B-cell pro-
genitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci
U S A. 2013; 110(24):E2199–208. doi: 10.1073/pnas.1222446110 PMID: 23716674; PubMed Central
PMCID: PMCPMC3683765.
33. Fiorina P, Vergani A, Dada S, Jurewicz M, Wong M, Law K, et al. Targeting CD22 reprograms B-cells
and reverses autoimmune diabetes. Diabetes. 2008; 57(11):3013–24. doi: 10.2337/db08-0420 PMID:
18689692; PubMed Central PMCID: PMCPMC2570398.
34. Ito T, Ishikawa S, Sato T, Akadegawa K, Yurino H, Kitabatake M, et al. Defective B1 cell homing to the
peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for sys-
temic lupus erythematosus. Journal of immunology. 2004; 172(6):3628–34. PMID: 15004165.
35. Martinez-Pomares L, Gordon S. CD169+macrophages at the crossroads of antigen presentation.
Trends in immunology. 2012; 33(64643542-4b36-93f7-554a-09a9eb923bed):66–136. doi: 10.1016/j.it.
2011.11.001
Immunoregulatory Islet Resident Macrophages in T1D
PLOSONE | DOI:10.1371/journal.pone.0150792 March 4, 2016 14 / 14
